Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB1 and CB2 receptors

European Journal of Pharmacology

Volumn 495, Issue 1, 2004, Pages 43-53

  Govaerts, Sophie J ^a   Muccioli, Giulio G ^a   Hermans, Emmanuel ^b   Lambert, Didier M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

3 Alkyl (5,5 diphenyl)imidazolidinedione; 35S GTP S; Cannabinoid receptor; Inverse agonism; Neutral antagonism

Indexed keywords

3 (1 HYDROXYPROPYL) 5,5' BIS(4 BROMOPHENYL)IMIDAZOLIDINEDIONE; 3 (2 ETHYLMORPHOLINO) 5,5' BIS(4 BROMOPHENYL)IMIDAZOLIDINEDIONE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; HYDANTOIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CEREBELLUM; CHO CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE HOMOGENATE;

ANIMALS; CEREBELLUM; CHO CELLS; CRICETINAE; CRICETULUS; DRUG EVALUATION, PRECLINICAL; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; IMIDAZOLIDINES; MALE; MOLECULAR STRUCTURE; MORPHOLINES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SPECIES SPECIFICITY; SPLEEN; STRUCTURE-ACTIVITY RELATIONSHIP; SULFUR RADIOISOTOPES; TRANSFECTION;

EID: 3042672851     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.05.023     Document Type: Article

References (45)

1. Adam J., Cowley P. Recent advances in the cannabinoids. Expert Opin. Ther. Pat. 12:2002;1475-1489
2. Barth F., Rinaldi-Carmona M. The development of cannabinoid antagonists. Curr. Med. Chem. 6:1999;745-755
3. 1. Biochem. J. 312:1995;637-641
4. Bouaboula M., Perrachon S., Michigan L., Canat X., Rinaldi-Carmona M., Portier M., Barth F., Calandra B., Pecceu F., Lupker J., Maffrand J.P., Casellas P. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J. Biol. Chem. 272:1997;22330-22339
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254
6. Breivogel C.S., Childers S.R. Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition. J. Pharmacol. Exp. Ther. 295:2000;328-336
7. 35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J. Biol. Chem. 273:1998;16865-16873
8. 2 cannabinoid receptor. Biochim. Biophys. Acta. 1576:2002;255-264
9. 1 receptor. Eur. J. Pharmacol. 374:1999;445-455
10. Deadwyler S.A., Hampson R.E., Mu J., Whyte A., Childers S. Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J. Pharmacol. Exp. Ther. 273:1995;734-743
11. Devane W.A., Dysarz F.A., Johnson M.R., Melvin L.S., Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34:1988;605-613
12. 1 receptors in vivo. J. Neurochem. 70:1998;417-423
13. 2+ channel current. Am. J. Physiol. 276:1999;H2085-H2093
14. Gérard C.M., Mollereau C., Vassart G., Parmentier M. Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279:1991;129-134
15. 35S]thio)-triphosphate binding assay in rat cerebellar membranes. J. Pharmacol. Exp. Ther. 285:1998;553-560
16. 2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 292:2000;886-894
17. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U. S. A. 87:1990;1932-1936
18. 1). J. Pharmacol. Exp. Ther. 289:1999;1427-1433
19. 35S]-GTPγS binding in the mouse brain. Eur. J. Pharmacol. 321:1997;R1-R3
20. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., Pertwee R.G. International Union of Pharmacology: XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54:2002;161-202
21. 1 receptor. Mol. Pharmacol. 62:2002;1274-1287
22. Kanyonyo M.R., Govaerts S.J., Hermans E., Poupaert J.H., Lambert D.M. 3-Alkyl-(5, 5′-diphenyl)imidazolidinediones as new cannabinoid receptor ligands. Bioorg. Med. Chem. Lett. 9:1999;2233-2236
23. 1 and the induction of GDP/GTP exchange. J. Neurochem. 72:1999;2379-2387
24. 1 receptor. Eur. J. Pharmacol. 334:1997;R1-R2
25. 1 receptor. Life Sci. 62:1998;PL109-PL113
26. 2) messenger RNA expression during in vitro stimulation of murine splenocytes with lipopolysaccharide. Adv. Exp. Med. Biol. 493:2001;223-228
27. Lutz B. Molecular biology of cannabinoid receptors. Prostaglandins, Leukot. Essent. Fat. Acids. 66:2002;123-142
28. Mackie K., Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. U. S. A. 89:1992;3825-3829
29. 2 receptors. Br. J. Pharmacol. 124:1998;619-622
30. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564
31. 35S]-GTPS binding assays. Trends Pharmacol. Sci. 24:2003;87-90
32. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65
33. 1 cannabinoid receptor ligands and potential antagonists: synthesis, lipophilicity, affinity, and molecular modeling. J. Med. Chem. 45:2002;1748-1756
34. 1 cannabinoid receptor activity. Mol. Pharmacol. 54:1998;1064-1072
35. Pertwee R.G. Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem. 6:1999;635-664
36. Portier M., Rinaldi-Carmona M., Pecceu F., Combes T., Poinot-Chazel C., Calandra B., Barth F., Le Fur G., Casellas P. SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist. J. Pharmacol. Exp. Ther. 288:1999;582-589
37. Rinaldi-Carmona M., Barth F., Héaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Néliat G., Caput D., Ferrara P., Soubrié P., Brelière J.C., Le Fur G. SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240-244
38. 2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284:1998;644-650
39. 35S]thio)triphosphate binding in rat brain membranes. Life Sci. 59:1996;659-668
40. 2 peripheral cannabinoid receptor. Biochim. Biophys. Acta. 1307:1996;132-136
41. 35S]thio]triphosphate binding. Proc. Natl. Acad. Sci. U. S. A. 92:1995;7242-7246
42. 35S]-GTPγS autoradiography in rat brain. J. Neurosci. 16:1996;8057-8066
43. Sim-Selley L.J., Brunk L.K., Selley D.E. Inhibitory effects of SR 141716A on G-protein activation in rat brain. Eur. J. Pharmacol. 414:2001;135-143
44. 1 receptor antagonists. Chem. Pharm. Bull. 50:2002;1109-1113
45. Weiland T., Jakobs K.H. Measurement of receptor-stimulated guanosine 5′-O-(gamma-thio)triphosphate binding by G proteins. Methods Enzymol. 237:1994;3-13